Johnson & Johnson Co DRC (JNJ)

10,372.00
-59.50(-0.57%)
  • Volume:
    2,886
  • Bid/Ask:
    10,374.00/10,425.00
  • Day's Range:
    10,344.00 - 10,614.00

JNJ Overview

Prev. Close
10,431.5
Day's Range
10,344-10,614
Revenue
47.45B
Open
10,590
52 wk Range
6,030-11,758
EPS
6.98
Volume
2,886
Market Cap
63.76T
Dividend (Yield)
0.5569
(0.78%)
Average Volume (3m)
3,760
P/E Ratio
23.69
Beta
0.589
1-Year Change
64.26%
Shares Outstanding
2,629,179,895
Next Earnings Date
-
What is your sentiment on Johnson & Johnson DRC?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson Co DRC News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Johnson & Johnson Co DRC Analysis

Johnson & Johnson Co DRC Company Profile

Johnson & Johnson Co DRC Company Profile

Employees
141700
Market
Argentina

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Consumer Health segment offers baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company’s Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Buy
SummaryStrong SellStrong SellStrong BuyStrong BuyStrong Buy